VVOS
Vivos Therapeutics
$0.40
+$0.01 (+2.54%)Jul 27, 2026
Key metrics
The numbers that frame VVOS today
- Market cap
- $5.60M
- P/E (TTM)
- -0.2
- EV / FCF
- -0.8
- Gross margin
- 61.8%
- EV / Sales
- 0.8
- ROIC
- -227.7%
- Div yield
- 0%
- 52wk Low
- $0.36
- 52wk High
- $5.69
Growth
Revenue and earnings trend for VVOS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VVOS
Is Vivos Therapeutics a good buy?
No. Vivos Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Vivos Therapeutics is selling at a very high price.
What is the market capitalization of VVOS?
Vivos Therapeutics's market capitalization is $5.60M.
What is the P/E ratio for VVOS stock?
Vivos Therapeutics's current P/E ratio is -0.2.
What is the 52-week high for VVOS stock?
The 52-week high for Vivos Therapeutics is $5.69. The current close of $0.40 is 92.9% below that high.
What is the 52-week low for VVOS stock?
The 52-week low for Vivos Therapeutics is $0.36. The current close of $0.40 is 10.7% above that low.
Does VVOS stock pay dividends?
Vivos Therapeutics does not currently show a dividend per share in the company data.